新型 コロナ ウイルス 感染 症 初期 症状 - 新型コロナウイルス初期症状・潜伏期間

コロナ ウイルス 感染 初期 症状 症 新型 新型コロナウイルス感染症について/千葉県

コロナ ウイルス 感染 初期 症状 症 新型 新型コロナウイルス感染症、分かりにくい症状とは?初期症状チェック方法について医師が解説します。

コロナ ウイルス 感染 初期 症状 症 新型 新型コロナウイルスに関するQ&A(一般の方向け)|厚生労働省

新型コロナウイルス感染症について

コロナ ウイルス 感染 初期 症状 症 新型 新型コロナウイルスに関するQ&A(一般の方向け)|厚生労働省

コロナ ウイルス 感染 初期 症状 症 新型 新型コロナウイルス感染症の初期症状としての嗅覚異常と味覚異常

新型コロナウイルス、現在の感染者・死者数(13日午後7時時点) 死者404.4万人に

コロナ ウイルス 感染 初期 症状 症 新型 新型コロナウイルス初期症状が明らかに

コロナ ウイルス 感染 初期 症状 症 新型 新型コロナウイルスの初期症状とは?感染者が語る発症例・経過まとめ

新型コロナウイルス感染症の初期症状を確実にとらえよう【自分と周囲の人のために】

コロナ ウイルス 感染 初期 症状 症 新型 新型コロナウイルスに関するQ&A(一般の方向け)|厚生労働省

コロナ ウイルス 感染 初期 症状 症 新型 新型コロナウイルスに関するQ&A(一般の方向け)|厚生労働省

新型コロナウイルス感染症について

コロナ ウイルス 感染 初期 症状 症 新型 症状、予防、経過と治療… 新型コロナウイルス感染症とは?

新型コロナウイルス感染症の初期症状としての嗅覚異常と味覚異常

Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019. The time course of the immune response to experimental coronavirus infection of man. A Novel Coronavirus from Patients with Pneumonia in China, 2019. Obes Rev 2020; 21 11 : e13128. MMWR Morbidity and mortality weekly report 2020; 69 24 : 759-65. Horby P, Lim WS, Emberson JR, et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. Beigel JH, Tomashek KM, Dodd LE, et al. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 COVID-19. Garrigues E, Janvier P, Kherabi Y, et al. Isaacs D, Flowers D, Clarke JR, Valman HB, MacNaughton MR. J Infect 2020; 81 2 : e16-e25. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. Prevalence and impact of diabetes among people infected with SARS-CoV-2. The New England journal of medicine 2020; 382 8 : 727-33. Cevik M, Kuppalli K, Kindrachuk J, Peiris M. Matsunaga N, Hayakawa K, Terada M, et al. The New England journal of medicine 2020; 383 13 : 1283-6. Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. Miyazato Y, Morioka S, Tsuzuki S, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers. Clinical Characteristics of Coronavirus Disease 2019 in China. Latif F, Farr MA, Clerkin KJ, et al. J Endocrinol Invest 2020; 43 6 : 867-9. Journal of clinical microbiology 2020; 58 8. Brenner EJ, Ungaro RC, Gearry RB, et al. Another false-positive problem for a SARS-CoV-2 antigen test in Japan. The Lancet Infectious diseases 2020. Fadini GP, Morieri ML, Longato E, Avogaro A. Otolaryngol Head Neck Surg 2020; 163 1 : 3-11. New England Journal of Medicine 2020. Mahdavinia M, Foster KJ, Jauregui E, et al. Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California. Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020. Ogawa T, Fukumori T, Nishihara Y, et al. Grein J, Ohmagari N, Shin D, et al. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. Gandhi RT, Lynch JB, Del Rio C. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. Michelena X, Borrell H, López-Corbeto M, et al. Characteristics and outcomes of COVID-19 in patients with HIV: a multicentre research network study. Asthma prolongs intubation in COVID-19. J Allergy Clin Immunol Pract 2020; 8 7 : 2388-91. Cell research 2020; 30 3 : 269-71. Oboho IK, Tomczyk SM, Al-Asmari AM, et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Klompas M, Morris CA, Shenoy ES. Myers LC, Parodi SM, Escobar GJ, Liu VX. Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19 REGISTRY JAPAN. Gastroenterology 2020; 159 1 : 81-95. Brooks JT, Butler JC, Redfield RR. Cheung KS, Hung IFN, Chan PPY, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Universal Masking to Prevent SARS-CoV-2 Transmission—The Time Is Now. Wang X, Ferro EG, Zhou G, Hashimoto D, Bhatt DL. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis. Gastroenterology 2020; 159 2 : 481-91. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Universal Masking in the Covid-19 Era. Allotey J, Stallings E, Bonet M, et al. Laboratory biosafety guidance related to coronavirus disease 2019 COVID-19 : interim guidance, 12 February 2020: World Health Organization, 2020. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. Journal of clinical microbiology 2010; 48 8 : 2940-7. The New England journal of medicine 2015; 372 9 : 846-54. Williams E, Bond K, Zhang B, Putland M, Williamson DA. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2020; 94: 91-5. Epidemiology and infection 1990; 105 2 : 435-46. Open Forum Infectious Diseases 2020. Epidemiology of coronavirus respiratory infections. New England Journal of Medicine 2020; 383 27 : 2603-15. Hadi YB, Naqvi SFZ, Kupec JT, Sarwari AR. Polack FP, Thomas SJ, Kitchin N, et al. Popkin BM, Du S, Green WD, et al. Stokes EK, Zambrano LD, Anderson KN, et al. Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE. The Lancet Oncology 2020; 21 3 : 335-7. Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2. Liang W, Guan W, Chen R, et al. Spinner CD, Gottlieb RL, Criner GJ, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. Archives of disease in childhood 1983; 58 7 : 500-3. MMWR Morbidity and mortality weekly report 2020; 69 25 : 769-75. The New England journal of medicine 2020. The Yale journal of biology and medicine 1974; 47 4 : 234-51. Persistent Symptoms in Patients After Acute COVID-19. The New England journal of medicine 2020; 383 2 : e9. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet London, England 2020; 395 10236 : 1569-78. Prolonged and late-onset symptoms of coronavirus disease 2019. Virology, transmission, and pathogenesis of SARS-CoV-2. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Cheng PK, Wong DA, Tong LK, et al. Callow KA, Parry HF, Sergeant M, Tyrrell DA. Ellington S, Strid P, Tong VT, et al. Lancet London, England 2020; 395 10223 : 497-506. Remdesivir for 5 or 10 days in patients with severe Covid-19. Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020. Wyllie AL, Fournier J, Casanovas-Massana A, et al. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Goldman JD, Lye DC, Hui DS, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus 2019-nCoV in vitro. The New England journal of medicine 2020; 383 18 : 1757-66. Lancet London, England 2004; 363 9422 : 1699-700. Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results. Semin Arthritis Rheum 2020; 50 4 : 564-70. J Clin Virol 2020; 131: 104612. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.。

新型コロナウイルス感染症まとめ

新型コロナウイルス感染症、分かりにくい症状4つ「咳と発熱だけではありません」

新型コロナウイルス感染症について

新型コロナウイルス感染症について【症状・臨床経過・予防策】

新型コロナウイルス感染症、分かりにくい症状4つ「咳と発熱だけではありません」

新型コロナウイルス感染症の初期症状を確実にとらえよう【自分と周囲の人のために】

新型コロナウイルスの初期症状とは?感染者が語る発症例・経過まとめ




2021 tmh.io